棉花糖直播

Recent clinical trials have demonstrated that T cells can be extracted from a patient, reprogrammed to attack leukemia cells, and then injected back into the patient to eradicate the target cells (e.g. B cells).  Our research aims to increase the efficiency of this process by optimizing the delivery and expression of foreign genes in T cells using CRISPR/Cas9-mediated genome editing.

Donated human blood is the safest and most effective treatment for severe blood loss.  However, since it is a cellular product, donated blood has to be constantly refrigerated and is consequently unavailable in remote areas and battlefields (where it is needed most).  We are currently investigating earthworm hemoglobin as a highly stable, safe, and effective substitute for donated blood.